PharmaForce Appoints Industry Leader Lynn Eschenbacher to Lead Next Phase of 340B Strategy and Execution
PharmaForce, a leader in modern 340B program management, today announced the appointment of Lynn Eschenbacher, PharmD, MBA, FASHP, as Chief Pharmacy and Strategy Officer, reinforcing its commitment to delivering enterprise-grade performance, operational discipline, and a forward-looking strategy for the evolving 340B landscape.
